Target intelligence / Profile preview

Pathogens, toxins, and autoantigens

Molecular classification
Other
01

Overview

Pathogens, toxins, and autoantigens represent a broad pharmacological category rather than a single molecular target. This classification, utilized by resources such as the IUPHAR/BPS Guide to Pharmacology, encompasses non-host biological entities (bacteria, viruses, fungi, and parasites), biochemical poisons (venoms and microbial toxins), and endogenous host molecules that become the target of an aberrant immune response (autoantigens) [1]. Pathogens are typically targeted by anti-infective agents that exploit differences between host and pathogen biology, such as bacterial cell wall synthesis or viral reverse transcription [2]. Toxins are addressed through neutralizing agents like antitoxins or chelators that prevent the substance from interacting with host receptors [1]. Autoantigens are the focus of therapies for autoimmune diseases, where the goal is to deplete the B-cells producing autoantibodies or to interfere with the antigen-presentation process [3]. Because this entry describes a high-level grouping of diverse biological and chemical threats, it is considered a category of targets rather than a specific protein or receptor [1].

Other names
Exogenous targetsNon-host targetsForeign antigensEnvironmental toxinsSelf-antigens
02

Mechanism of action

Therapeutic intervention involves the neutralization of toxins, inhibition of pathogen replication (e.g., cell wall synthesis or viral protease inhibition), or the modulation/suppression of the immune response against self-derived autoantigens.

03

Biological functions

PathogenesisToxicityAutoimmunityImmune responseInfection
04

Disease associations

InfectionPoisoningAutoimmune diseaseInflammationEnvenomation
05

Safety considerations

Antimicrobial resistanceDisruption of the commensal microbiomeSystemic immunosuppressionInfusion reactionsSerum sickness
06

Interacting drugs

Penicillin

5 more in the full profile.

07

Biomarkers

Pathogen-specific DNA/RNASerum toxin levelsAutoantibody titers (e.g., anti-CCP, anti-dsDNA)C-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Pathogens, toxins, and autoantigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogens, toxins, and autoantigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call